Market
What will be the impact on Sanofi's revenue growth in China from 2025 to 2027?
2
Resolution / Starting Odds
Less than 5% increase • 25%
5% to 10% increase • 25%
10% to 15% increase • 25%
More than 15% increase • 25%
Sanofi's annual financial reports or industry analysis
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Largest Single Investment for Beijing Insulin Production
Dec 2, 2024, 04:39 PM
Sanofi, the French pharmaceutical company, has announced plans to invest approximately 1 billion euros ($1.05 billion) to establish a new insulin production facility in Beijing. This investment marks Sanofi's largest single investment in China to date. The announcement follows a meeting between China's Commerce Minister Wang Wentao and Sanofi's Chairman Frédéric Oudéa, where Wang emphasized China's commitment to providing a favorable business environment for pharmaceutical companies. This development comes amid ongoing trade tensions between China and the European Union, highlighting Sanofi's strategic move to strengthen its presence in the Chinese market.
View original story
Similar markets
No significant change • 25%
Increase by over 10% • 25%
Increase by less than 5% • 25%
Increase by 5-10% • 25%
Remain the same • 25%
Decrease • 25%
Increase • 25%
Other • 25%
Improved relations • 25%
No change • 25%
Worsened relations • 25%
Other • 25%
Project halted • 25%
Project delayed • 25%
Project unaffected • 25%
Project expedited • 25%
Partially operational • 25%
Other • 25%
Not operational • 25%
Fully operational • 25%
No • 50%
Yes • 50%
10% to 15% • 25%
More than 15% • 25%
Less than 5% • 25%
5% to 10% • 25%
More than 15% increase • 25%
Less than 5% increase • 25%
10% to 15% increase • 25%
5% to 10% increase • 25%
Growth below 5% • 25%
No growth • 25%
Growth above 10% • 25%
Growth 5-10% • 25%
Over 10% growth • 25%
Negative growth • 25%
5-10% growth • 25%
0-5% growth • 25%